Entity Detail — Knowledge Graph Node
This page aggregates everything SciDEX knows about HIF-1: its mechanistic relationships (Knowledge Graph edges), hypotheses targeting it, analyses mentioning it, and supporting scientific papers. The interactive graph below shows its immediate neighbors. All content is AI-synthesized from peer-reviewed literature.
No summary available yet.
No AI portrait yet
| Name | HIF-1 |
| Key Genes/Proteins | VEGF |
Knowledge base pages for this entity
graph TD
HIF_1["HIF-1"]
style HIF_1 fill:#1a237e,stroke:#4fc3f7,stroke-width:3px
HIF_1 -->|"activates"| Als["Als"]
HIF_1 -->|"activates"| Cancer["Cancer"]
HIF_1 -->|"activates"| Ferroptosis["Ferroptosis"]
HIF_1 -.->|"inhibits"| Ischemia["Ischemia"]
HIF_1 -.->|"inhibits"| Fibrosis["Fibrosis"]
HIF_1 -->|"activates"| Aging["Aging"]
HIF_1 -->|"regulates"| Neuroinflammation["Neuroinflammation"]
TKT([TKT]) -->|"activates"| HIF_1
IDH2([IDH2]) -->|"activates"| HIF_1
TIGAR([TIGAR]) -->|"activates"| HIF_1
FOXO([FOXO]) -->|"activates"| HIF_1
HK2([HK2]) -->|"activates"| HIF_1
MYC([MYC]) -->|"activates"| HIF_1
PKM2([PKM2]) -->|"activates"| HIF_1
GLUT1([GLUT1]) -->|"activates"| HIF_1
GSK3([GSK3]) -->|"activates"| HIF_1
MTORC1([MTORC1]) -->|"activates"| HIF_1| Target | Relation | Type | Str |
|---|---|---|---|
| VEGF | upregulates | protein | 0.85 |
| Neuroinflammation | regulates | disease | 0.60 |
| Neurodegeneration | regulates | disease | 0.60 |
| Alzheimer | regulates | disease | 0.60 |
| Als | regulates | disease | 0.60 |
| Depression | activates | disease | 0.60 |
| Neurodegeneration | inhibits | disease | 0.60 |
| Glioblastoma | activates | disease | 0.60 |
| Als | transports | disease | 0.60 |
| Ferroptosis | activates | disease | 0.60 |
| Ferroptosis | inhibits | disease | 0.60 |
| Ischemia | inhibits | disease | 0.60 |
| Cancer | inhibits | disease | 0.60 |
| Fibrosis | inhibits | disease | 0.60 |
| Aging | activates | disease | 0.60 |
| Cancer | regulates | disease | 0.60 |
| Parkinson | regulates | disease | 0.60 |
| Neurodegeneration | associated_with | disease | 0.60 |
| Cancer | activates | disease | 0.60 |
| Als | activates | disease | 0.60 |
| Stroke | regulates | disease | 0.60 |
| Apoptosis | inhibits | pathway | 0.55 |
| Pi3K/Akt | inhibits | pathway | 0.55 |
| Glycolysis | activates | pathway | 0.55 |
| Apoptosis | contributes_to | pathway | 0.55 |
| Pi3K/Akt | activates | pathway | 0.55 |
| Mtor | activates | pathway | 0.55 |
| Autophagy | activates | pathway | 0.55 |
| Mapk | associated_with | pathway | 0.55 |
| Autophagy | regulates | pathway | 0.55 |
| Oxidative Stress | inhibits | pathway | 0.55 |
| Mtor | regulates | pathway | 0.55 |
| Epigenetic | regulates | pathway | 0.55 |
| Oxidative Stress | associated_with | pathway | 0.55 |
| Blood-Brain Barrier | regulates | pathway | 0.55 |
| Mtor | therapeutic_target | pathway | 0.55 |
| Blood-Brain Barrier | activates | pathway | 0.55 |
| Apoptosis | activates | pathway | 0.55 |
| Oxidative Stress | activates | pathway | 0.55 |
| Wnt | inhibits | pathway | 0.55 |
| Cholesterol | regulates | pathway | 0.55 |
| Immune Response | regulates | pathway | 0.55 |
| Lipid Metabolism | regulates | pathway | 0.55 |
| Glycolysis | regulates | pathway | 0.55 |
| Nf-Κb | therapeutic_target | pathway | 0.55 |
| Source | Relation | Type | Str |
|---|---|---|---|
| MTORC1 | activates | gene | 0.60 |
| AMPK | activates | gene | 0.60 |
| FOXO | activates | gene | 0.60 |
| PKM2 | activates | gene | 0.60 |
| GLUT1 | activates | gene | 0.60 |
| GSK3 | activates | gene | 0.60 |
| EIF4B | activates | gene | 0.60 |
| FERROPTOSIS | activates | gene | 0.60 |
| PABP1 | activates | gene | 0.60 |
| CHAC2 | activates | gene | 0.60 |
| HIF | activates | gene | 0.60 |
| HIF1 | regulates | gene | 0.60 |
| MICROGLIA | activates | gene | 0.60 |
| BCL-2 | expressed_in | gene | 0.60 |
| CX43 | activates | gene | 0.60 |
| APOPTOSIS | inhibits | gene | 0.60 |
| STROKE | regulates | gene | 0.60 |
| G3BP1 | activates | gene | 0.60 |
| SLC7A11 | inhibits | gene | 0.60 |
| OCLN | activates | gene | 0.60 |
| HMOX1 | activates | gene | 0.60 |
| CD4 | activates | gene | 0.60 |
| ABCA7 | regulates | gene | 0.60 |
| LPL | regulates | gene | 0.60 |
| APOE4 | regulates | gene | 0.60 |
| SYK | regulates | gene | 0.60 |
| TREM2 | associated_with | gene | 0.60 |
| PPARG | regulates | gene | 0.60 |
| APOE | associated_with | gene | 0.60 |
| CNTN1 | therapeutic_target | gene | 0.60 |
| NGF | therapeutic_target | gene | 0.60 |
| BDNF | activates | gene | 0.60 |
| HCRTR1 | activates | gene | 0.60 |
| WIF1 | inhibits | gene | 0.60 |
| LDHB | activates | gene | 0.60 |
| DJ-1 | regulates | gene | 0.60 |
| RNA | regulates | gene | 0.60 |
| PARKINSON | regulates | gene | 0.60 |
| AUTOPHAGY | regulates | gene | 0.60 |
| SLC16A1 | activates | gene | 0.60 |
| GBM | activates | gene | 0.60 |
| ANGPT1 | associated_with | gene | 0.60 |
| PIK3R1 | associated_with | gene | 0.60 |
| UCHL1 | activates | gene | 0.60 |
| VEGFA | activates | gene | 0.60 |
| ANGPT1 | activates | gene | 0.60 |
| UBIQUITIN | activates | gene | 0.60 |
| SNCA | regulates | gene | 0.60 |
| PARK7 | regulates | gene | 0.60 |
| CASPASE3 | expressed_in | gene | 0.60 |
Hypotheses where this entity is a therapeutic target
| Hypothesis | Score | Disease | Analysis |
|---|---|---|---|
| Targeting SASP-Complement Amplification Through HIF-1α Downs | 0.793 | neurodegeneration | What molecular mechanism causes VCP muta |
| Moderate hyperoxia (1.5-2.0 ATA) optimally stabilizes HIF-1α | 0.470 | neurodegeneration | What are the optimal oxygen pressure, du |
Scientific analyses that reference this entity
neurodegeneration | 2026-04-13 | 2 hypotheses Top: 0.793
Experimental studies targeting or related to this entity
| Experiment | Type | Disease | Score | Feasibility | Model | Status | Est. Cost |
|---|---|---|---|---|---|---|---|
| Single-cell RNA sequencing analysis of human atherosclerotic plaques | exploratory | Atherosclerosis | 0.900 | 0.00 | Human atherosclerotic plaque s | proposed | N/A |
Scientific publications cited in analyses involving this entity
| Title & PMID | Authors | Journal | Year | Citations |
|---|---|---|---|---|
| No papers found | ||||
Multi-agent debates referencing this entity
Hypotheses and analyses mentioning HIF-1 in their description or question text
No additional research found